Navigation Links
Olympus Corporation of the Americas Names Mark Gumz President & CEO
Date:4/1/2008

CENTER VALLEY, Pa., April 1, 2008 /PRNewswire/ -- Olympus, a precision technology leader creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, announced today that F. Mark Gumz, president and chief operating officer of the global company's wholly owned subsidiary in the U.S. since January 2000, will add chief executive officer to his title, effective immediately. His new position will utilize his longstanding experience with Olympus and the leadership skills developed over his 30-year career on behalf of the nearly 2,500 employees of Olympus companies in the Americas. Also as of today, the Olympus Corporation holding company that provides shared services for all Olympus companies in the Americas, of which Gumz becomes CEO, will be renamed from Olympus USA Incorporated to Olympus Corporation of the Americas (OCA) to better reflect its regional geographic responsibility for North and South American Olympus operations.

"Mark's new position is part of a long-term plan to continue to position Olympus and its subsidiaries for success, to meet market needs and to best serve our customers through a region-specific management strategy executed around the world," said Tsuyoshi ("Tom") Kikukawa, president of Tokyo-based Olympus Corp. (TSE 7733). "His appointment will also help position the organization to better respond to customer needs, and his knowledge of Japanese culture and of our company makes him the perfect choice for CEO of this new company."

Gumz is the highest-ranking official in the Americas and the first American to be appointed CEO of any Olympus entity. He will retain his positions as president of Olympus America Inc. (OAI), Olympus Canada Inc. (OCI), Olympus Imaging America Inc. (OIMA) and Olympus Medical Equipment Services America Inc. (OMES). He also continues to oversee the operations of Olympus Latin America Inc.

Gumz said, "I look forward to my expanded leadership role with Ol
'/>"/>

SOURCE Olympus Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. A Picture Perfect Partnership: Olympus Raises Colorectal Cancer Awareness Through eBay Giving Works Auction
2. Olympus Announces 2008 Winners of Olympus Innovation Awards
3. HealthSouth Finalizes Sale of Corporate Campus to Daniel Corporation
4. CRH Medical Corporation opens new center in Pembroke Pines Florida
5. Response Biomedical Corporation Reports 2007 Financial Results
6. China Medicine Corporation to Present at Brean Murray Carret & Co. Mainland China Investor Tour
7. Baxa Corporation Launches Call for Research Papers
8. Beatrice Community Hospital and Health Center Selects Zix Corporation for Email Encryption Service
9. CRH Medical Corporation opens new center in Denver, Colorado
10. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
11. Toxikon Corporation to Hold Medical Device and Testing Seminar Next Month

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... who were treated with cisplatin-based chemotherap...ical side effects and Raynaud-like phenomena, than...ding to a new study published online November 25 i..., Marianne Brydy, M.D., of the Department of Onc...orway, and colleagues conducted a cross-sectional ...
(Date:11/25/2009)...f a collaboration between UCLA engineers and physi...0 million Americans who suffer from peripheral art...the arteries, peripheral arterial disease, or PAD,... arteries reduce blood flow to the limbs. The cond...e, heart attack and stroke, and its progression ca...
(Date:11/25/2009)...o draw definite conclusions, experts say, , ...iabetic patients with blocked coronary arteries, t...e year whether patients undergo bypass surgery or ...ort. , Bypass surgery has been the standard tre...disease. However, less invasive approaches such as...
(Date:11/25/2009)...reatment clinics to resume Monday, Nov. 30 , ... 2009 -- Centegra Health System is continuing to o... four Centegra Primary Care (CPC) vaccination clin... The clinics are at CPC sites in Huntley, Woodstoc...llows: ,   From 4:30 to 7:30 p.m. Tues...
(Date:11/25/2009)...mptoms, study finds , , WEDNESDAY, Nov....are among the potential problems faced by long-ter...with cisplatin-based chemotherapy, a new study has...n treated for unilateral testicular cancer between... conducted from 1998 to 2002. , The researchers...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...lity drugs to get pregnant can breathe a sigh of r...he popular medications used to increase the number...e do not increase the risk of ovarian cancer. // ...ad difficulty conceiving took fertility drugs and ...
...ated that Men who suffer from constipation are mor...in disease Parkinson's some have suggested that th...f the gut long before it manifests itself elsewher...high risk of developing the disease in the future....
...ng under polluted, hazy skies move away to communi...ore quickly, according to a study by researchers a...dicine researchers followed more than 100 children...affected annual rates of lung function growth, the...
...euths found that the absence of a certain protein ... water levels.Reported in the New England journal ...ey works.// The protein aquaporin-1has a d...ency of the protein have a limited ability to reab...
... bagged the registration, production and marketing...he Centre for Biotechnology in the Jawaharlal Nehr...e would be in the market in 3-4 months. The Compan...t to make any projections on the business the vacc...
...covered that frequent sexual intercourse can actua...attack.Middle aged men can have sex as many times/...f having a stroke, according to research. P...between sex and strokes. The team based its findin...
Other Medicine News:Health News:Particulate matter affects lung development 2
(Date:11/25/2009)...Call/--Hologic,Inc.(HologicortheCompany)(Nasdaq: H...remiumdiagnostics,medicalimagingsystemsandsurgical...n,isusingtheannualmeetingoftheRadiologicalSocietyo...ber29throughDecember3,2009tohighlightournewSecurVi...stationsoftware. ,, TheHologicSecurViewworkstat...
(Date:11/25/2009)...dsResearchGroup,Inc.releasedWave1ofits LaunchTren...yndicatedmarketresearchprojecttrackingthelaunchofC...oughthefirstsixmonthsofavailability.Eachwaveofther...rmatologistsandqualitativeinformationfromasubsetof...ouse,typicalpatienttypes,productperceptions,promot...
(Date:11/25/2009)...e/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAmeric...hatitreceivedtheEnvironmentalResponsibilityandSust...mmit,sponsoredbytheCaliforniaManufacturersandTechn...ssociation(IEA)andtheChemicalIndustryCouncilofCali...sawardavailablefromallthreeorganizationsandgainssu...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 1AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 2AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 3AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 4AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 5AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 6AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 7AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 8AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 9AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 10AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 11AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 12AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 13AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 14AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 15AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 16AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 17AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 18AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 1AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 2AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 3First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 1First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 2First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 3
...in treating pediatric acute lymphoblastic,leukemia...ians treat,adolescents and adults with the disease... that has occurred in the cure rate for children w...ficult to replicate in older,patients without cons...cle,by St. Jude Children,s Research Hospital autho...
... NanoBio Corporation,announced today that it has ... its phase 2 study of NB-002, a topical lotion for... remain confidential, the results clearly,justify ...sts., "Allowing adequate time for subjects to gro... infection will enable us to generate data on,comp...
Other Medicine Technology:Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers 2NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 2
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: